Phase of Development: Hit to Lead

Mechanism of Action: Tau Synthesis/Expression/RNA Modulation

Compound Type/Modality: Small Molecule

Brain penetrant small molecules drugs that target tau pre-mRNA and modulate 3R to 4R tau splicing

Matthew Disney, PhD

Professor, Department of Chemistry
Scripps Research Institute, Florida Campus

For further information about this program Contact: